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Introduction
L
ipids  are  one  of  the  necessary  components 
which  control  cellular  functions  and 
homeostasis.  Liver  plays  an  essential  role  in  lipid 
metabolism,  several  stages  of  lipid  synthesis  and 
transportation. Therefore, it is reasonable to expect 
an abnormal lipid profile in those with sever liver 
dysfunction. There is prominent decline in plasma 
cholesterol and triglyceride (TG) levels in patients 
with severe hepatitis and hepatic failure because of 
reduction of lipoprotein biosynthesis. For reduced 
liver  biosynthesis  capacity,  low  levels  of  TG  and 
cholesterol  is  usually  observed  in  chronic  liver 
diseases (1).
Major complications of cirrhosis include portal 
hypertension,  esophageal  varices,  hepatomegaly, 
hypersplenism,  ascites,  spontaneous  bacterial 
peritonitis,  hepatorenal  syndrome  type  I  and  II,   
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Background and Aims: An impaired lipid metabolism is often observed in patients with chronic liver diseases. To determine 
lipid profile in patients with cirrhosis and to asses if it relates to the severity of the cirrhosis.
Materials and Methods: In an analytical cross-sectional study, 50 patients with cirrhosis (case) and 50 age- and sex-
matched healthy normolipidemic patients (comparison) were studied. A questionnaire including personal characteristics, 
etiology  of  cirrhosis,  pathologic  criteria  of  CHILD  and  MELD  and  lipid  profile  (total,  LDL,  and  HDL  cholesterol  and 
triglyceride) was completed for each patient. 
Results: In patients with cirrhosis, there was a significant decrease in serum triglyceride, total, LDL and HDL cholesterol 
levels compared to the comparison group (mean of 82 vs 187, 138 vs 184, 80 vs 137, and 40 vs 44 mg/dL, respectively; all 
p<0.05). Comparison of lipid profile with pathologic progression of cirrhosis revealed that except for serum triglyceride 
level, serum lipid levels diminishe linearly with progression of liver damage. 
Conclusions: Serum total, LDL and HDL cholesterol level in patients with cirrhosis is inversely correlate with severity of 
cirrhosis.
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hepatic encephalopathy, hepatopulmonary syndrome, 
malnutrition,  coagulapathy,  fibrinolysis  factor 
deficiency,  thrombocytopenia,  bone  disorders, 
osteopenia,  osteoporosis,  osteomalacia,  hematologic 
disorders,  anemia,  hemolysis,  neutropenia,  diabetes 
mellitus, cancer, heart or renal failure, pancreatitis, 
etc (2-4). Cirrhotic patients need frequent visits and 
multiple hospitalizations for management of cirrhosis 
or its complications. However, choosing the proper 
treatment plan depends on the severity, type of liver 
damage  and  possibility  of  assessing  its  extent.  To 
evaluate cirrhosis, Child-Turcotte-Pough criteria can be 
used (2). In addition, MELD criteria are used to choose 
liver transplantation candidates which are substituted 
by PELD criteria for children under 12 years (5). AS 
mentioned  earlier,  metabolism  of  TG,  cholesterol 
and synthesis of lipoproteins predominantly occurs 
in liver and various parenchymal diseases may lead 
to  alterations  in  lipoproteins  structure  and  transfer 
through the blood (6). Although, several studies have 
been performed on lipoprotein profile alterations in 
those with liver disease, contributions from Iran are 
scarce. Despite diverse results, some outcomes have 
been observed to be common (7-15). Due to the high 
prevalence of chronic liver disease in our country, we 
conducted  this  study  to  determine  lipid  profile  in 
patients with cirrhosis and to assess if it relates to the 
severity of cirrhosis. 
Materials And Methods
In  an  analytical  cross-sectional  study,  out  of 
212 cirrhotic patients admitted between 2005 and 
2008 to Kamkar Hospital, a referral center in Qom, 
Central  Iran,  50  patients  were  selected  to  enroll 
into our study, after excluding those with diabetes 
mellitus,  cancer,  renal  failure,  acute  pancreatitis, 
and  acute  gastrointestinal  bleeding,  and  patients 
with  history  of  hyperlipidemia,  recent  parenteral 
nutrition,  history  of  taking  glucose  or  lipid 
lowering drugs. A questionnaire including personal 
characteristics such as age, gender and etiology of 
cirrhosis (e.g., HBV, HCV, drugs and toxins, chronic 
liver  congestion,  Wilson's  disease,  autoimmune 
hepatitis, hemochromatosis, α1-antitripsin deficiency 
and cryptogenic cirrhosis) was completed for each 
patient. Then the diagnostic method used for the 
diagnosis of cirrhosis was determined. The methods 
included either liver biopsy or combination of clinical 
signs and symptoms and sonography. The next part 
of the questionnaire included presence of ascites and/
or encephalitis grading in a 3-point scale according 
to Child criteria. Serum TG level, total, HDL and 
LDL cholesterol were then measured. Finally, Child-
Turcotte-Pough and MELD criteria were calculated 
for each patient as an index for the extent of liver 
damage.
Furthermore, 50 age- and sex-matched healthy 
normolipidemic  people,  referring  to  the  hospital 
laboratory were selected as our comparison group 
and their serum lipid profile was measured. Data were 
analyzed by SPSS. χ2, one-way analysis of variance 
(ANOVA) and Student’s t test were used. A p value 
<0.05 was considered statistically significant.
Results
In our study, the most common causes of cirrhosis 
were HBV (53%) followed by cryptogenic cirrhosis 
(18%) (Table 1). The most affected age group was 
41  to  50  years  so  that  90%  of  cirrhotic  patients 
were over 41 years of age. There was a significant 
(p=0.03)  difference  in  the  frequency  of  cirrhotic 
patients  among  different  age  groups.  Fifty-eight 
percent of patients were male and 42% were female. 
According to Child criteria, 11 (22%) patients had 
score “A,” 14 (28%) score “B,” and 25 (50%) had 
score “C.” According to MELD criteria, 10 patients 
had scores <10, 15 had scores between 11 and 18, 
17 between 19 and 24, and 8 had scores>25. There 
was  a  significant  (p<0.05)  negative  correlation 
between  liver  damage—according  to  MELD  and 
Child  criteria—and  serum  total,  HDL  and  LDL 
cholesterol level (p<0.05) (Table 2). The more severe 
the liver damage is, the more decline in lipid levels 
is detected, especially in LDL and total cholesterol 
levels. However, no correlation was observed between 
the serum TG level and the extent of liver damage. 
All four variables (HDL, LDL, total cholesterol and 
TG)  were  significantly  lower  in  cirrhotic  patients 
than in the comparison group (Table 3).
Table 1. Causes of cirrhosis in patients
n %
Cumulative frequency 
(%)
HBV 27 53 53
HCV 4 8 61
HCB and HCV 2 4 65
Autoimmune 2 4 69
Chronic hepatitis congestion 4 8 76
Wilson’s disease 1 2 78
Hemochromatosis 2 4 82
Cryptogenic cirrhosis 9 18 100
Total 51 100Hepat Mon. 2010; 10(4): 285-288
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Discussion 
We  found  that  lower  lipid  levels  are  found  in 
patients  with  liver  diseases,  and  all  four  studied 
variables  (HDL,  LDL,  total  cholesterol  and  TG) 
were  significantly  lower  in  cirrhotic  patients  than 
in the comparison group. Furthermore, the amount 
of decrement in the serum HDL, LDL and total 
cholesterol (but not TG) had a positive correlation 
with the severity of liver damage.
The  significant  decline  in  the  serum  total 
cholesterol  and  TG  levels  in  cirrhotic  patients 
compared with healthy people has been confirmed 
earlier in other studies, which is reasonably expected 
since  liver  biosynthesis  has  been  reduced.  For 
instance, the same results were obtained in a study 
by Mehbob, et al, in 2007, who studied 160 patients 
with chronic liver diseases. There were significant 
declines in the serum total cholesterol and TG levels 
of patients. Another study in Greece was performed 
by Siagris on 155 patients infected with HCV and 
138 healthy people who served as the comparison 
group, where the serum total cholesterol level was 
lower in patients than the comparison group. Final 
results were correlated with total cholesterol and LDL 
and in cases of genotype 3a, lower levels of TG, HDL 
and LDL, higher levels of hepatitis C viral load and 
higher grade of liver steatosis were found comparing 
to other genotypes. In this study, the final results 
also  showed  that  liver  damage  is  correlated  with 
total cholesterol, HDL and LDL but not with TG 
levels. Salimoghlou found that HDL level is lower in 
Child-Pugh B than Child-Pugh A and apo-A level is 
the most affected factor in those with liver damage. 
In this study, the change in HDL level was higher in 
Child A than B, and higher in Child B than C which 
shows that that is the severity of liver function that 
causes HDL level to decline.
Perales found that in patients with chronic liver 
disease without cholestasis, LDL, HDL and VLDL 
levels  decline  and  become  worse  as  the  disease 
progresses.  This  finding  is  in  keeping  with  our 
observations that in severe liver disease as the liver 
function deteriorates, more decline is observed in 
LDL, HDL and total cholesterol levels. In a study 
performed  by  Cicognanic  there  was  an  obvious 
decline  in  total  cholesterol  level  in  patients  with 
chronic liver disease in comparison with controls. 
In our study, a significant difference was observed 
between patients and the comparison group in all 
lipid profile values studied (p<0.05). 
It  is  therefore  concluded  that  the  amount  of 
Table 2. Lipid profile in patients with liver damage according to Child 
and MELD criteria. All data are presented as mean±SD.
n LDL (mg/dL) HDL (mg/dL)
Total cholesterol 
(mg/dL)
TG (mg/dL)
Child A 11 107.6±29.5 49.0±21.6 166.5±37.9 121.9±57.7
Child B 14 96.4±58.5 40.0±14.3 161.2±71.5 90.6±50.5
Child C 25 59.5±28.9 37.4±15.5 121.2±31.7 92.0±48.7
MELD ≤10 10 98.3±25.4 51.5±20.6 156.2±34.5 111.5±57.4
11≤MELD≤18 15 96.9±62.1 39.0±14.9 162.1±73.4 98.2±44.7
19≤MELD≤24 17 69.7±30.8 36.8±16.8 124.7±35.3 96.5±58.1
MELD ≥25 8 50.0±24.8 31.8±10.4 104.0±26.0 85.3±48.4
Table 3. Mean values of lipid profiles in cirrhotic patients in 
comparison with the comparison group
Lipid
Cirrhotic patients 
(mg/dL)
Comparison group 
(mg/dL)
p value
LDL cholesterol 80.5 137.2 0.025
HDL cholesterol 40.7 44.5 0.043
Total cholesterol 138.9 184.6 0.030
TG 82.2 187.8 0.011Hepat Mon. 2010; 10(4): 285-288
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decrements  measured  in  the  levels  of  serum  total 
cholesterol, LDL and HDL in patients with cirrhosis 
are  related  to  the  progress  in  cirrhosis.  Further 
studies are needed to assess the predictive values of 
measuring lipid profiles as a mean to estimate the 
extent of liver damage in cirrhotic patients.
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